Changes in composition and activities of 26S proteasomes under the action of doxorubicin--apoptosis inductor of erythroleukemic K562 cells

scientific article published on 21 January 2007

Changes in composition and activities of 26S proteasomes under the action of doxorubicin--apoptosis inductor of erythroleukemic K562 cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CELLBI.2007.01.018
P698PubMed publication ID17346995

P50authorIrina KozhukharovaQ57013148
Alexey G MittenbergQ62139936
P2093author name stringIrina M Konstantinova
Larisa N Gause
Valentina A Kulichkova
Anna S Tsimokha
P433issue4
P304page(s)338-348
P577publication date2007-01-21
P1433published inCell Biology InternationalQ1254690
P1476titleChanges in composition and activities of 26S proteasomes under the action of doxorubicin--apoptosis inductor of erythroleukemic K562 cells
P478volume31

Reverse relations

cites work (P2860)
Q37124125A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome.
Q33699632Activation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy.
Q33976943DNA damage modulates interactions between microRNAs and the 26S proteasome
Q39884346Exogenous 26S proteasomes can enter living cells to influence gene expression in the recipient cells.
Q38654368Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity.
Q47280042Proteomic analysis of affinity-purified extracellular proteasomes reveals exclusively 20S complexes.
Q37188091Role of proteasomes in cellular regulation
Q50450422Simultaneous EGFP and tag labeling of the β7 subunit for live imaging and affinity purification of functional human proteasomes.
Q37788836The role of the proteasome in heart disease

Search more.